Latest Period
Q1 2026
Security Snapshot
Nuvation Bio Inc. - Common Stock (NUVB) Institutional Ownership
CUSIP: 67080N101
13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026
Institutions Reporting
227
Shares (Excl. Options)
220,275,173
Price
$4.29
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- NUVB on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 220,275,173
- Total 13F value
- $944,851,153
- Portfolio coverage rank
- 0%
- Share change
- +7,024,438
- Value change
- -$2,599,959
- Number of holders
- 227
- Shares outstanding
- 339,200,672
- SEC-reported price per share
- $4.32
- Insider filing price
- $4.32
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NUVB - Nuvation Bio Inc. - Common Stock is tracked under CUSIP 67080N101.
- 227 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 223 to 227 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,893,184,000 to $944,851,153.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 227 institutions filings for Q1 2026.
Security key
67080N101
Latest holder period
Q1 2026
13F holders
227
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
NUVB full holder history
Nuvation Bio Inc. SEC filings
Nuvation Bio Inc. company facts
Nuvation Bio Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 67080N101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
NUVB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | +11% | $110,306,310 | +$11,583,764 | 50,599,225 | +12% | FMR LLC | 31 Mar 2025 |
| BlackRock, Inc. | 6.4% | +30% | $42,332,244 | +$10,273,842 | 21,708,843 | +32% | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Mar 2026, 227 institutional investors reported holding 220,275,173 shares of Nuvation Bio Inc. - Common Stock (NUVB). This represents 65% of the company’s total 339,200,672 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
55%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 51,989,593 | +1.1% | 0.01% | $223,035,355 |
| Decheng Capital LLC | 7.7% | 25,954,439 | 0% | 17% | $111,344,543 |
| BlackRock, Inc. | 7.4% | 25,100,374 | +1.7% | 0% | $107,680,605 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 11,626,198 | 0% | 0% | $49,876,389 |
| Omega Fund Management, LLC | 2.4% | 8,081,089 | 0% | 21% | $34,667,872 |
| Laurion Capital Management LP | 2.3% | 7,822,638 | -0.38% | 3.1% | $33,559,117 |
| STATE STREET CORP | 2% | 6,784,927 | +16% | 0% | $29,107,337 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 5,863,654 | +2.6% | 0% | $25,160,269 |
| Duquesne Family Office LLC | 1.3% | 4,539,800 | 0.66% | $19,476,000 | |
| BANK OF AMERICA CORP /DE/ | 0.95% | 3,219,826 | -15% | 0% | $13,813,054 |
| Redmile Group, LLC | 0.93% | 3,153,256 | -0.32% | 0.9% | $13,527,468 |
| TANG CAPITAL MANAGEMENT LLC | 0.93% | 3,149,557 | -18% | 0.69% | $13,511,600 |
| AMERICAN CENTURY COMPANIES INC | 0.85% | 2,897,078 | +7769% | 0.01% | $12,428,473 |
| TWO SIGMA INVESTMENTS, LP | 0.79% | 2,684,089 | +265% | 0.01% | $11,514,742 |
| Jones Hill Capital LP | 0.7% | 2,383,031 | 0% | 2.2% | $10,223,203 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.67% | 2,275,446 | 0% | 0% | $9,761,663 |
| CITADEL ADVISORS LLC | 0.61% | 2,065,411 | +1430% | 0.01% | $8,860,614 |
| DIMENSIONAL FUND ADVISORS LP | 0.61% | 2,052,691 | -0.66% | 0% | $8,806,044 |
| Qube Research & Technologies Ltd | 0.6% | 2,042,312 | +59% | 0.01% | $8,761,518 |
| NORTHERN TRUST CORP | 0.59% | 2,003,108 | +4.2% | 0% | $8,593,333 |
| AQR CAPITAL MANAGEMENT LLC | 0.59% | 1,995,758 | +20% | 0% | $8,561,802 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.59% | 1,992,451 | -1.2% | 0% | $8,547,615 |
| GOLDMAN SACHS GROUP INC | 0.57% | 1,929,953 | +14% | 0% | $8,279,498 |
| MORGAN STANLEY | 0.55% | 1,871,217 | +47% | 0% | $8,027,522 |
| ALGERT GLOBAL LLC | 0.54% | 1,842,078 | +533% | 0.12% | $7,903,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q1 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 220,275,173 | $944,851,153 | -$2,599,959 | $4.29 | 227 |
| 2025 Q4 | 211,333,629 | $1,893,184,000 | -$57,998,580 | $8.96 | 223 |
| 2025 Q3 | 220,537,335 | $817,798,856 | -$1,495,817 | $3.70 | 201 |
| 2025 Q2 | 224,729,650 | $439,155,420 | +$34,613,471 | $1.95 | 179 |
| 2025 Q1 | 207,335,118 | $364,911,263 | +$18,852,443 | $1.76 | 159 |
| 2024 Q4 | 197,748,566 | $526,027,669 | +$38,581,638 | $2.66 | 159 |
| 2024 Q3 | 187,137,100 | $428,593,958 | +$73,128,321 | $2.29 | 153 |
| 2024 Q2 | 153,048,262 | $446,948,909 | +$52,594,408 | $2.92 | 146 |
| 2024 Q1 | 134,652,746 | $490,113,918 | +$5,142,866 | $3.64 | 122 |
| 2023 Q4 | 134,270,272 | $202,718,680 | -$2,287,216 | $1.51 | 116 |
| 2023 Q3 | 136,892,011 | $183,439,434 | -$9,239,486 | $1.34 | 122 |
| 2023 Q2 | 139,011,387 | $250,194,724 | +$3,219,600 | $1.80 | 120 |
| 2023 Q1 | 137,479,282 | $228,214,660 | -$4,709,474 | $1.66 | 126 |
| 2022 Q4 | 139,580,600 | $267,992,788 | -$12,224,298 | $1.92 | 123 |
| 2022 Q3 | 141,780,239 | $317,588,133 | -$44,323,294 | $2.24 | 116 |
| 2022 Q2 | 155,298,098 | $503,167,223 | -$21,514,875 | $3.24 | 116 |
| 2022 Q1 | 159,104,350 | $836,898,347 | +$14,198,236 | $5.26 | 112 |
| 2021 Q4 | 155,258,449 | $1,319,350,594 | +$21,011,876 | $8.50 | 103 |
| 2021 Q3 | 151,280,175 | $1,503,381,648 | +$33,688,697 | $9.94 | 97 |
| 2021 Q2 | 147,981,823 | $1,364,632,796 | +$15,849,184 | $9.31 | 97 |
| 2021 Q1 | 145,559,447 | $1,478,100,000 | +$1,473,836,329 | $10.45 | 72 |